{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.3","value":"38.8"},{"groupId":"OG001","spread":"21.5","value":"29.2"}]}],"title":"MFSI-SF General"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.3","value":"12.2"},{"groupId":"OG001","spread":"15.1","value":"5.7"}]}],"title":"MFSI-SF Physical"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.8","value":"8.9"},{"groupId":"OG001","spread":"14.9","value":"2.6"}]}],"title":"MFSI-SF Mental"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.4","value":"8.0"},{"groupId":"OG001","spread":"16.8","value":"8.7"}]}],"title":"MFSI-SF Emotional"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.6","value":"13.4"},{"groupId":"OG001","spread":"13.8","value":"12.0"}]}],"title":"MFSI-SF Vigor"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.7","value":"27.3"},{"groupId":"OG001","spread":"15.2","value":"22.3"}]}],"title":"BFI Total Interference"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.0","value":"40.9"},{"groupId":"OG001","spread":"19.0","value":"37.0"}]}],"title":"LASA Fatigue"}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"description":"Changes in fatigue as measured using subscales of MFSI-SF, the interference scale of the BFI and the linear analogue scale (LASA) fatigue question were compared between arms for those participants who express a perceived change in fatigue via the global impression score of a +2 (moderately better) and +3 (very much better).","dispersionType":"Standard Deviation","groups":[{"description":"Patients received oral American ginseng twice daily for 14 days. This treatment was repeated every two weeks for 4 courses, for a total of 8 weeks of treatment.","id":"OG000","title":"Ginseng"},{"description":"Patients received oral placebo twice daily for 14 days. This treatment was repeated every two weeks for 4 courses, for a total of 8 weeks of treatment.","id":"OG001","title":"Placebo"}],"paramType":"MEAN","populationDescription":"Includes all participants who completed both baseline and week 4 assessments with a perceived change in fatigue via the global impression score of a +2 and +3 at week 4.","reportingStatus":"POSTED","timeFrame":"Baseline and Week 4","title":"Average Change From Baseline to Week 4 in Fatigue for Those Who Perceive a Change of +2 and +3","type":"SECONDARY","unitOfMeasure":"units on a scale"}